Consensus Acadia Healthcare Company, Inc.

Equities

ACHC

US00404A1097

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
73.59 USD +0.29% Intraday chart for Acadia Healthcare Company, Inc. +4.89% -5.36%

Evolution of the average Target Price on Acadia Healthcare Company, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5a413db5dd32cecf642.Uh7HN4_hZ2cP2JTD_IyP-eME68FsEU8D4sb5BW8uwcY.HSqVBL6rVQVekvPuubS-wYhthrUWfCc3qazNSCJWq6sqXep9tqYfHWuL1Q~11c35f9e94655db07c6284a1da570ac5
Deutsche Bank Upgrades Acadia Healthcare to Hold From Sell, Price Target is $70 MT
Mizuho Securities Price Target on Acadia Healthcare to $84 From $77, Maintains Neutral Rating MT
TD Cowen Adjusts Price Target on Acadia Healthcare to $101 From $86, Maintains Outperform Rating MT
Deutsche Bank Raises Acadia Healthcare Price Target to $70 From $68, Maintains Sell Rating MT
UBS Raises Acadia Healthcare Price Target to $102 From $88, Maintains Buy Rating MT
Stephens Upgrades Acadia Healthcare to Overweight From Equalweight, Raises Price Target to $92 From $81 MT
RBC Cuts Price Target on Acadia Healthcare to $94 From $99, Keeps Outperform Rating MT
Cantor Fitzgerald Adjusts Price Target on Acadia Healthcare to $85 From $83, Maintains Neutral Rating MT
Deutsche Bank Adjusts Acadia Healthcare Price Target to $68 From $63, Maintains Sell Rating MT
RBC Lifts Price Target on Acadia Healthcare to $99 From $93, Cites 'Strong Results With Momentum Expected to Continue,' Keeps Outperform Rating MT
UBS Adjusts Acadia Healthcare Price Target to $88 From $92, Maintains Buy Rating MT
Credit Suisse Raises Acadia Healthcare's Price Target to $95 From $93 After Above-Consensus Q1 Results, Keeps Outperform Rating MT
UBS Adjusts Acadia Healthcare's Price Target to $92 From $96, Maintains Buy Rating MT
Deutsche Bank Downgrades Acadia Healthcare to Sell From Hold, Adjusts Price Target to $63 From $75 MT
Deutsche Bank Adjusts Acadia Healthcare Price Target to $75 From $82, Maintains Hold Rating MT
Mizuho Lowers Price Target on Acadia Healthcare to $80 From $87, Maintains Neutral Rating MT
Stephens Adjusts Acadia Healthcare's Price Target to $88 From $92, Keeps Equalweight Rating MT
Acadia Healthcare Price Target From RBC Cut to $93 From $94 Despite View for Double-Digit Growth Through 2028, Outperform Kept MT
Loop Capital Upgrades Acadia Healthcare to Buy From Hold, Price Target is $95 MT
Stephens Adjusts Price Target on Acadia Healthcare Company to $88 From $86, Maintains Equalweight Rating MT
Mizuho Securities Adjusts Price Target on Acadia Healthcare Company to $87 From $80, Maintains Neutral Rating MT
Stephens Adjusts Acadia Healthcare's Price Target to $86 From $85, Keeps Equalweight Rating MT
Mizuho Securities Adjusts Acadia Healthcare Company's Price Target to $80 From $78, Keeps Neutral Rating MT
UBS Adjusts Acadia Healthcare Company Price Target to $96 From $90, Maintains Buy Rating MT
SVB Securities Adjusts Acadia Healthcare's Price Target to $103 From $95, Maintains Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
73.38 USD
Average target price
95.85 USD
Spread / Average Target
+30.62%
High Price Target
105 USD
Spread / Highest target
+43.09%
Low Price Target
70 USD
Spread / Lowest Target
-4.61%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Acadia Healthcare Company, Inc.

Deutsche Bank Securities
Mizuho Securities
TD Cowen
UBS
Stephens Inc.
RBC Capital Markets
Cantor Fitzgerald
Credit Suisse
Loop Capital
SVB Securities LLC
Raymond James
Barclays
SVB Leerink
Cowen
Citigroup
Seaport Global Securities
BofA Securities
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
  1. Stock Market
  2. Equities
  3. ACHC Stock
  4. Consensus Acadia Healthcare Company, Inc.